Promoting Awareness of Inflammatory Breast CancerPromoting Awareness of Inflammatory Breast Cancer
(MedPage Today) — Despite recent progress in understanding the disease, inflammatory breast cancer (IBC) remains a challenge to diagnose and treat, and the prognosis remains worse than for breast cancer in general.
IBC accounts for 2% to 4% of…
Supplemental Breast Cancer Screening in Women With Dense BreastsSupplemental Breast Cancer Screening in Women With Dense Breasts
(MedPage Today) — In 2023, the FDA updated its mammography regulations, with a key amendment that required facilities to provide information to patients regarding the density of their breasts.
This amendment featured specific language explaining…
Ozempic Improves Glycemic Control, Cuts Weight in Schizophrenia PatientsOzempic Improves Glycemic Control, Cuts Weight in Schizophrenia Patients
(MedPage Today) — Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose schizophrenia was being treated with the second-generation antipsychotics clozapine or olanzapine. The… (MedPage Today) — Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose schizophrenia was Read More
Breast cancer remodels lymphatic vessels to accelerate its spread, research revealsBreast cancer remodels lymphatic vessels to accelerate its spread, research reveals
Breast cancer is able to modify the lymphatic vessels through which it travels to the draining lymph nodes. From there, it can then spread to other parts of the body. A new finding by Finnish researchers may help develop targeted therapies that could prevent this spread.
WHO issues first guidance on using GLP-1 drugs to treat obesityWHO issues first guidance on using GLP-1 drugs to treat obesity
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.
Study Finds Significant Number of Breast Cancers in Women Under 40Study Finds Significant Number of Breast Cancers in Women Under 40
(MedPage Today) — Women younger than 50 accounted for about a quarter of all breast cancers diagnosed at a large community imaging practice in New York, with a substantial number in women under age 40, a retrospective review found.
Of the nearly…
GLP-1 drugs may reach fewer than one in 10 people who need them, experts predictGLP-1 drugs may reach fewer than one in 10 people who need them, experts predict
The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity. GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide-1 (GLP-1), which are most commonly used for type 2 diabetes and medical weight loss. The first guideline, released on Dec. 1, aims to address the Read More
Omomyc enhances PARP inhibitor effects and overcomes resistance in breast cancer modelsOmomyc enhances PARP inhibitor effects and overcomes resistance in breast cancer models
Findings from a preclinical study demonstrate that Omomyc—the only direct MYC inhibitor to have successfully completed a phase I clinical trial—causes DNA damage in cancer cells which is synergistically enhanced in combination with poly (ADP-ribose) polymerase inhibitors (PARPi).
GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in KidsGLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids
(MedPage Today) — Weight-loss injectables for pets? Okava Pharmaceuticals announced plans to kick off a pilot study of a GLP-1 drug for cats with obesity. (New York Times) Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to… (MedPage Today) — Weight-loss injectables for pets? Okava Pharmaceuticals announced plans to kick off a pilot Read More
Taking a drug like Ozempic? What you need to know about risks of suicidal thoughts and contraception failureTaking a drug like Ozempic? What you need to know about risks of suicidal thoughts and contraception failure
The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat diabetes, these drugs are now widely used for weight loss and have become household names. The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat Read More